Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Description

Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.

Conditions

Rheumatic Joint Disease

Talk to us

Study Overview

On this page

Study Details

Study overview

Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Condition
Rheumatic Joint Disease
Intervention / Treatment

-

Contacts and Locations

Birmingham

University of Alabama at Birmingham, Birmingham, Alabama, United States, 35233

Phoenix

Phoenix Children's Hospital, Phoenix, Arizona, United States, 85254

Los Angeles

Children's Hospital of Los Angeles, Los Angeles, California, United States, 90027

Los Angeles

Mattel Children's Hospital at University of California Los Angeles, Los Angeles, California, United States, 90095

Palo Alto

Stanford University Medical Center, Palo Alto, California, United States, 94304

San Diego

Rady Children's Hospital San Diego, San Diego, California, United States, 92123

San Francisco

University of California at San Francisco Medical Center, San Francisco, California, United States, 94143

Aurora

The Children's Hospital of Colorado, Aurora, Colorado, United States, 80045

Hartford

Connecticut Children's Medical Center, Hartford, Connecticut, United States, 06106

New Haven

Yale University, New Haven, Connecticut, United States, 06519

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Onset of rheumatic disease prior to age 16 years for JIA and onset prior to age 19 years for all other rheumatic diseases (see appendix A).
  • 2. Subject (and/or parent/legal guardian when required) is able to provide written informed consent and willing to comply with study procedures.
  • 3. Subject and/or parent/legal guardian is willing to be contacted in the future by study staff.
  • 1. Greater than 21 years of age at the time of enrollment.

Ages Eligible for Study

to 21 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Duke University,

Mara L Becker, MD, MSCE, PRINCIPAL_INVESTIGATOR, Duke Clinical Research Insitute

Mary Beth Son, MD, PRINCIPAL_INVESTIGATOR, Boston Children's Hospital

Timothy Beukelman, MD, MSCE, PRINCIPAL_INVESTIGATOR, University of Alabama at Birmingham

Study Record Dates

2028-12